As new C. diff treatments prep for market, specialists divided on 'poop in a pill' or small molecule, study finds
What do physicians think about the emerging market for recurrent C. diff? That depends on who you talk to, especially which specialists you talk to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
